International Biotechnology Trust as of June 30, 2023
Portfolio Holdings for International Biotechnology Trust
International Biotechnology Trust holds 61 positions in its portfolio as reported in the June 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Amgen (AMGN) | 7.9 | $26M | 117k | 221.97 | |
Incyte Corporation (INCY) | 6.8 | $22M | 359k | 62.22 | |
Harmony Biosciences Hldgs In (HRMY) | 6.1 | $20M | 571k | 35.18 | |
Regeneron Pharmaceuticals (REGN) | 5.9 | $19M | 27k | 718.52 | |
Supernus Pharmaceuticals (SUPN) | 4.8 | $16M | 524k | 30.06 | |
Vera Therapeutics Cl A (VERA) | 4.8 | $16M | 975k | 16.04 | |
Alnylam Pharmaceuticals (ALNY) | 4.7 | $16M | 82k | 189.94 | |
Apellis Pharmaceuticals (APLS) | 3.6 | $12M | 130k | 91.06 | |
United Therapeutics Corporation (UTHR) | 3.5 | $12M | 53k | 220.76 | |
Intra Cellular Therapies (ITCI) | 3.4 | $11M | 177k | 63.23 | |
Gilead Sciences (GILD) | 3.4 | $11M | 145k | 77.03 | |
Illumina (ILMN) | 2.9 | $9.5M | 51k | 187.39 | |
Mirati Therapeutics | 2.9 | $9.4M | 260k | 36.13 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 2.2 | $7.4M | 21k | 351.75 | |
Revance Therapeutics (RVNC) | 2.2 | $7.3M | 289k | 25.28 | |
Horizon Therapeutics SHS | 2.1 | $6.9M | 67k | 102.85 | |
Travere Therapeutics (TVTX) | 2.1 | $6.8M | 441k | 15.35 | |
Neurocrine Biosciences (NBIX) | 2.0 | $6.5M | 69k | 94.23 | |
Karuna Therapeutics Ord | 1.7 | $5.6M | 26k | 216.60 | |
Aurinia Pharmaceuticals (AUPH) | 1.7 | $5.6M | 574k | 9.68 | |
Denali Therapeutics (DNLI) | 1.7 | $5.5M | 188k | 29.46 | |
Krystal Biotech (KRYS) | 1.6 | $5.4M | 46k | 117.30 | |
BioMarin Pharmaceutical (BMRN) | 1.5 | $5.1M | 59k | 86.66 | |
Madrigal Pharmaceuticals (MDGL) | 1.3 | $4.2M | 18k | 231.00 | |
Axsome Therapeutics (AXSM) | 1.3 | $4.2M | 58k | 71.80 | |
Erasca (ERAS) | 1.2 | $3.9M | 1.4M | 2.75 | |
Ultragenyx Pharmaceutical (RARE) | 1.1 | $3.7M | 80k | 46.11 | |
Akero Therapeutics (AKRO) | 1.1 | $3.7M | 79k | 46.66 | |
ACADIA Pharmaceuticals (ACAD) | 1.1 | $3.6M | 151k | 23.95 | |
Halozyme Therapeutics (HALO) | 1.0 | $3.4M | 96k | 36.06 | |
Dyne Therapeutics (DYN) | 1.0 | $3.4M | 301k | 11.25 | |
Biogen Idec (BIIB) | 1.0 | $3.1M | 11k | 284.79 | |
Rocket Pharmaceuticals (RCKT) | 0.9 | $3.1M | 156k | 19.83 | |
Legend Biotech Sponsored Ads (LEGN) | 0.8 | $2.6M | 38k | 69.03 | |
Zai Lab Adr (ZLAB) | 0.7 | $2.2M | 79k | 27.73 | |
Sarepta Therapeutics (SRPT) | 0.7 | $2.2M | 19k | 114.52 | |
Jazz Pharms. Shs Usd (JAZZ) | 0.6 | $2.1M | 17k | 123.94 | |
Ionis Pharmaceuticals (IONS) | 0.5 | $1.8M | 43k | 41.02 | |
Mirum Pharmaceuticals (MIRM) | 0.5 | $1.7M | 68k | 25.82 | |
Celldex Therapeutics Com New (CLDX) | 0.5 | $1.6M | 48k | 33.89 | |
Beigene Sponsored ADR | 0.5 | $1.5M | 8.7k | 177.97 | |
Novocure Ord Shs (NVCR) | 0.4 | $1.3M | 32k | 41.49 | |
Guardant Health (GH) | 0.4 | $1.3M | 37k | 35.77 | |
Cytokinetics Com New (CYTK) | 0.4 | $1.2M | 37k | 32.59 | |
Xenon Pharmaceuticals (XENE) | 0.3 | $982k | 26k | 38.50 | |
Intellia Therapeutics (NTLA) | 0.3 | $978k | 24k | 40.74 | |
Marinus Pharmaceuticals Com New (MRNS) | 0.3 | $977k | 90k | 10.86 | |
Sage Therapeutics (SAGE) | 0.3 | $939k | 20k | 46.97 | |
I-mab- Sponsored Ads (IMAB) | 0.3 | $925k | 311k | 2.98 | |
Insmed (INSM) | 0.3 | $845k | 40k | 21.08 | |
Hutchmed China Sponsored Ads (HCM) | 0.2 | $816k | 68k | 12.00 | |
Beam Therapeutics (BEAM) | 0.2 | $750k | 24k | 31.93 | |
Ptc Therapeutics I (PTCT) | 0.2 | $692k | 17k | 40.69 | |
Agios Pharmaceuticals (AGIO) | 0.2 | $680k | 24k | 28.32 | |
Protagonist Therapeutics (PTGX) | 0.2 | $549k | 20k | 27.60 | |
Amylyx Pharmaceuticals (AMLX) | 0.2 | $539k | 25k | 21.54 | |
Ventyx Biosciences (VTYX) | 0.1 | $491k | 15k | 32.76 | |
Iovance Biotherapeutics (IOVA) | 0.1 | $457k | 65k | 7.03 | |
Arvinas Ord (ARVN) | 0.1 | $421k | 17k | 24.77 | |
Uniqure Nv SHS (QURE) | 0.1 | $178k | 16k | 11.46 | |
Relmada Therapeutics (RLMD) | 0.0 | $25k | 10k | 2.47 |